Table 4.
Patient genotype by dosing group.
| *1/*1 | *1/*2 | *1/*3 | *2/*2 | *2/*3 | *3/*3 | Total | ||
| Standard | n | 13 | 3 | 2 | 0 | 1 | 1 | 20 |
| % | 65.0 | 15.0 | 10.0 | 0.0 | 5.0 | 5.0 | ||
| Model-based | n | 11 | 4 | 0 | 2 | 1 | 0 | 18 |
| % | 61.1 | 22.2 | 0.0 | 11.1 | 5.6 | 0.0 | ||
| Total | 24 | 7 | 2 | 2 | 2 | 1 | 38 |
Patient genotype by dosing group.
| *1/*1 | *1/*2 | *1/*3 | *2/*2 | *2/*3 | *3/*3 | Total | ||
| Standard | n | 13 | 3 | 2 | 0 | 1 | 1 | 20 |
| % | 65.0 | 15.0 | 10.0 | 0.0 | 5.0 | 5.0 | ||
| Model-based | n | 11 | 4 | 0 | 2 | 1 | 0 | 18 |
| % | 61.1 | 22.2 | 0.0 | 11.1 | 5.6 | 0.0 | ||
| Total | 24 | 7 | 2 | 2 | 2 | 1 | 38 |